Element Biosciences raises another massive round

Off Biotech, biotechnology, Business, cancer, drug development, drug prices, drug pricing, FDA, finance, genetics, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello! Today, we talk about an Illumina competitor’s newest influx of funding, Adam weighs in on Pfizer’s plan for a once-a-day GLP-1 pill, and more.

Read the rest…

Read Original Article: Element Biosciences raises another massive round »

About The Author